Technical Analysis for CRSP - CRISPR Therapeutics AG
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Flat |
| Historical CRSP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 2.31% | |
| NR7 | Range Contraction | -1.63% | |
| Multiple of Ten Bullish | Other | -1.63% | |
| 20 DMA Resistance | Bearish | -0.10% | |
| Multiple of Ten Bearish | Other | -0.10% | |
| 20 DMA Resistance | Bearish | -2.64% | |
| Multiple of Ten Bullish | Other | -2.64% | |
| Outside Day | Range Expansion | -2.64% | |
| 20 DMA Resistance | Bearish | -2.93% | |
| NR7 | Range Contraction | -2.93% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 5 minutes ago |
| Up 5% | 5 minutes ago |
| 200 DMA Resistance | about 4 hours ago |
| 10 DMA Resistance | about 4 hours ago |
| Rose Above 10 DMA | about 5 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/26/2021
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Acid Immune System Genetics Enzymes Precision Medicine Serious Diseases Genetic Engineering DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 220.15 |
| 52 Week Low | 46.01 |
| Average Volume | 2,030,581 |
| 200-Day Moving Average | 117.92 |
| 50-Day Moving Average | 134.91 |
| 20-Day Moving Average | 121.46 |
| 10-Day Moving Average | 117.98 |
| Average True Range | 7.92 |
| ADX | 21.75 |
| +DI | 16.14 |
| -DI | 24.60 |
| Chandelier Exit (Long, 3 ATRs ) | 113.24 |
| Chandelier Exit (Short, 3 ATRs ) | 130.26 |
| Upper Bollinger Band | 135.54 |
| Lower Bollinger Band | 107.38 |
| Percent B (%b) | 0.25 |
| BandWidth | 23.18 |
| MACD Line | -4.75 |
| MACD Signal Line | -5.43 |
| MACD Histogram | 0.6806 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 121.50 | ||||
| Resistance 3 (R3) | 121.28 | 118.69 | 120.32 | ||
| Resistance 2 (R2) | 118.69 | 116.88 | 118.80 | 119.92 | |
| Resistance 1 (R1) | 116.54 | 115.76 | 115.24 | 116.76 | 119.53 |
| Pivot Point | 113.94 | 113.94 | 113.30 | 114.06 | 113.94 |
| Support 1 (S1) | 111.80 | 112.13 | 110.50 | 112.02 | 109.25 |
| Support 2 (S2) | 109.20 | 111.01 | 109.31 | 108.86 | |
| Support 3 (S3) | 107.05 | 109.20 | 108.46 | ||
| Support 4 (S4) | 107.28 |
